The Campaign
The brief was to increase sales and raise awareness of Symprove, a natural supplement drink that is clinically proven to treat IBS. To create stand-out in a cluttered marketplace, our strategy was an evidence-backed communications campaign that promoted the efficacy of Symprove.
Activity included:
- Consumer research on the rise of IBS and its impact on sufferers
- Patient case study placement
- Announcement of King’s College Hospital IBS trial results at Digestive Disease Week in San Diego
- Broadcast and video campaign involving gastroenterologists and patients
The Results
- Helped Symprove break the £1million turnover barrier in just five months through PR
- More than six million Irritable Bowel Syndrome (IBS) sufferers reached with the Symprove message
- Blanket coverage in the consumer and health media, including the Daily Mail, Mail on Sunday, Sunday Times, Daily Mirror, Daily Express, This Morning, as well as several BBC radio stations and social media platforms
What the client said...
“With our new and unique probiotic product, the first to be clinically proven for Irritable Bowel Syndrome, coming to market, PR has been an essential part of raising awareness to our customers and healthcare practitioners. Justine Rawlins PR has secured a significant amount of coverage for us. This ranged from lead stories in the national press, a powerful spot on national Breakfast TV as well as a large number of relevant magazines. These achievements had a significant impact on sales and were an important part of our marketing strategy.”
